Blepharitis surgery: Difference between revisions
No edit summary |
mNo edit summary |
||
Line 10: | Line 10: | ||
===Intraductal Meibomian Gland Probing=== | ===Intraductal Meibomian Gland Probing=== | ||
Invasive orifice penetration and intraductal probing is usually reserved for patients with severe posterior blepharitis and [[meibomian gland]] dysfunction (MGD).<ref name="pmid20622668">{{cite journal| author=Maskin SL| title=Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction. | journal=Cornea | year= 2010 | volume= 29 | issue= 10 | pages= 1145-52 | pmid=20622668 | doi=10.1097/ICO.0b013e3181d836f3 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20622668 }} </ref> | Invasive orifice penetration and intraductal probing is usually reserved for patients with severe posterior blepharitis and [[meibomian gland]] dysfunction (MGD).<ref name="pmid20622668">{{cite journal| author=Maskin SL| title=Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction. | journal=Cornea | year= 2010 | volume= 29 | issue= 10 | pages= 1145-52 | pmid=20622668 | doi=10.1097/ICO.0b013e3181d836f3 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20622668 }} </ref> | ||
===Thermal Pulsation=== | ===Thermal Pulsation=== | ||
Thermal pulsation system, which include LipiFlow have demonstrated significant improvements in both signs and symptoms of patients with meibomian gland dysfunction. | Thermal pulsation system, which include LipiFlow have demonstrated significant improvements in both signs and symptoms of patients with meibomian gland dysfunction. | ||
Line 21: | Line 22: | ||
[[Category:Immunology]] | [[Category:Immunology]] | ||
[[Category:Primary care]] | [[Category:Primary care]] | ||
[[Category:FinalQCRequired]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 19:54, 27 July 2016
Blepharitis Microchapters | |
Diagnosis | |
---|---|
Treatment | |
Case Studies | |
Blepharitis surgery On the Web | |
American Roentgen Ray Society Images of Blepharitis surgery | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
Surgical intervention is not the first-line treatment option for patients with blepharitis. Surgery is usually reserved for patients with complications, such as chalazion, entropion, ectropion, or horizontal eyelid laxity.[1][2]
Surgery
Surgery is not the firstline treatment option for patients with blepharitis. Surgery is usually reserved for patients with complications, such as chalazion, entropion, ectropion, or horizontal eyelid laxity.[1][2]
Intraductal Meibomian Gland Probing
Invasive orifice penetration and intraductal probing is usually reserved for patients with severe posterior blepharitis and meibomian gland dysfunction (MGD).[3]
Thermal Pulsation
Thermal pulsation system, which include LipiFlow have demonstrated significant improvements in both signs and symptoms of patients with meibomian gland dysfunction. Thermal pulsation provides heat and gentle pressure on the eyelid to liquefy and release obstructions in the meibomian glands.[4]
References
- ↑ 1.0 1.1 Qiao J, Yan X (2013). "Emerging treatment options for meibomian gland dysfunction". Clin Ophthalmol. 7: 1797–803. doi:10.2147/OPTH.S33182. PMC 3772773. PMID 24043929.
- ↑ 2.0 2.1 Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T; et al. (2011). "The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction". Invest Ophthalmol Vis Sci. 52 (4): 2050–64. doi:10.1167/iovs.10-6997g. PMC 3072163. PMID 21450919.
- ↑ Maskin SL (2010). "Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction". Cornea. 29 (10): 1145–52. doi:10.1097/ICO.0b013e3181d836f3. PMID 20622668.
- ↑ Lane SS, DuBiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR; et al. (2012). "A new system, the LipiFlow, for the treatment of meibomian gland dysfunction". Cornea. 31 (4): 396–404. doi:10.1097/ICO.0b013e318239aaea. PMID 22222996.